why choose us

Clinical Trials Search

Showing 19,490 of 132,963 result(s)
A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy

Status: Completed

Condition: Facioscapulohumeral Muscular Dystrophy (FSHD)

Interventions: Participants will receive subcutaneous (SC) placebo every 4 weeks (Q4W)

Date: 2022-09-16

DAY101 vs. Standard of Care Chemotherapy in Pediatric Patients With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC;FIREFLY-2)

Status: Completed

Condition: Low-grade Glioma

Interventions: Oral pan-RAF inhibitor

Date: 2022-09-16

Positron Emission Tomography (PET) Trial to Evaluate Target Occupancy of CVL-354 at Kappa and Mu Opioid Receptors in Brain Following Oral Dosing

Status: Completed

Condition: Opioid Use Disorder

Interventions: Oral solution;capsule

Date: 2022-09-16

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities

Status: ACTIVE_NOT_RECRUITING

Condition: Obesity

Interventions: Administered SC

Date: 2022-09-16

Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women

Status: Completed

Condition: Pregnancy Related

Interventions: Candlelit Care is a virtual perinatal mental health application that builds on cognitive behavioral therapy (CBT) to provide Black, Indigenous and POC

Date: 2022-09-16

Diabetic Cardiomyopathy and Heart Failure

Status: NOT_YET_RECRUITING

Condition: Diabetic Cardiomyopathies

Interventions: Oral administration of a probiotic

Date: 2022-09-16

Mobile Health Program for Rural Hypertension

Status: Completed

Condition: Hypertension,Essential

Interventions: A digital application for providing education and support for home-based blood pressure monitoring.

Date: 2022-09-15

Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2

Status: Completed

Condition: Neurotrophic Keratopathy

Interventions: A preservative-free, sterile eye drop solution containing T?4 for direct instillation into study eye(s), five times per day for 28 days

Date: 2022-09-15

Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Study of ALXN1820 in Adult Participants With Sickle Cell Disease

Status: ACTIVE_NOT_RECRUITING

Condition: Sickle Cell Disease (SCD)

Interventions: ALXN1820 will be administered subcutaneously.

Date: 2022-09-15

Time Lapse Assisted Embryo Selection Versus Non Invasive PGT-A Assisted Embryo Selection

Status: Completed

Condition: Infertility

Interventions: The basis of embryo seletion for transfer: morphological or genetic after non-invasive PGT-A

Date: 2022-09-15